The IPO Buzz: Medtronic’s MiniMed (MMED Proposed) Sets Terms for $742 Million IPO
MiniMed (MMED Proposed), a Medtronic spin-off, pulled back the curtain early today on its IPO. The Northridge, California-based company - a pioneer in diabetic care with its wearable automated insulin pump and other devices - is offering 28 million shares at a price range of $25.00 to $28.00 to raise $742 million, if priced at the $26.50 mid-point of its range. MiniMed would have a market cap of ..
Read more February 24, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Brookline Capital Acquisition Corp. II | BCACU | 10.0 | $ 100.0 mil | 2/27/2026 Friday | S/O | S/O |
| Generate Biomedicines | GENB | 25.0 | $ 400.0 mil | 2/27/2026 Friday | S/O | S/O |
| Iron Dome Acquisition I Corp. | IDACU | 20.0 | $ 200.0 mil | 2/27/2026 Friday | S/O | S/O |
Last 100 IPOs - February 25, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 54 |
| Number Down: | 40 |
| Number Unchanged: | 6 |
| Percentage Change From Issue Price: | -2.85% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - February 25, 2026
| Number of IPOs priced (Excluding 45 units) : | 28 |
| Number Up: | 15 |
| Number Down: | 9 |
| Number Unchanged: | 4 |
| Total Return From Issue Price: | 7.94% |
| The Nasdaq Composite Index YTD % Change | 35.22% |